Teva begins trading ordinary shares on NYSE; ADS program terminated

TEVA PHARMACEUTICAL INDUSTRIES LTD

Effective Sept 14, 2026, Teva ordinary shares trade on NYSE under 'TEVA', replacing ADSs.
Each American depositary share exchanged for one ordinary share; ADS program terminated.
Shares continue to trade on Tel Aviv Stock Exchange under same symbol 'TEVA'.
Ticker unchanged, but security type changes from ADS to ordinary share.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.